ZYBT
Zhengye Biotechnology Holding Limited
1.20$
-1.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 14.9% | 6.7% | 22.8% | 22.0% | 11.5% | |
| 7.5% | 7.2% | 11.3% | 13.0% | 22.3% | |
| -15.7% | -25.7% | -9.7% | -0.5% | 38.5% | |
| 12.3% | 10.5% | 5.5% | 14.9% | 10.9% | |
| -12.3% | -10.5% | -5.6% | – | -10.9% | |
| 5.2% | 8.2% | 18.6% | 8.6% | 13.8% | |
| 3.7% | 13.4% | 11.8% | -1.5% | -10.4% | |
| -1.4% | 5.2% | -9.0% | -11.9% | 27.8% | |
| 1.2% | 1.3% | 8.2% | -4.6% | 27.3% | |
| 2.5% | -3.8% | 17.3% | 7.1% | 0.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.